Dementia Test on IPad

A dementia diagnosis usually starts with a family member noticing that something isn’t quite right: a partner becoming forgetful, a normally placid parent losing their temper more often. From there, there are doctor’s appointments—memory and behavior tests that haven’t changed in years, brain scans if the money is there, or one of the battery of new blood tests looking for the biomarkers of brain damage. And then: nothing.

Neurodegenerative diseases like dementia and Alzheimer’s are more feared than cancer and heart disease combined, according to a 2016 survey, and one of the most frightening things about them is how little we still know. There are no cures, and few effective treatments.

So you might question the benefits of a 5-minute test that can assess your risk of getting dementia before you show any symptoms. The Integrated Cognitive Assessment (ICA) test, developed by the British startup Cognetivity Neurosciences, has been granted Food and Drug Administration clearance to be marketed in the United States and is being trialled at several NHS trusts in the UK. But is there any point in taking a test for a disease you can’t do anything about?

The ICA is designed as a “semi-supervisedscreening test, says Cognetivity CEO Sina Habibi. It could form part of an annual health check-up for the over-50s, looking for the earliest signs of neurodegenerative disease before they become apparent in behavior.In the same way you look at blood pressure, you could look at the brain with a cognitive test to see if there’s something malfunctioning,” he says.

An early diagnosis could help people plan ahead and put their affairs in order—but arguably that’s something they should probably be doing anyway. Lifestyle tweaks such as eating less fat, exercising more, or drinking less can also reduce risk, particularly in vascular dementia, which is caused by poor blood supply to the brain and is therefore closely linked to heart health.

The procedure runs on an iPad. A zebra appears onscreen and then disappears, replaced by a railway bridge. There are flashes of beach scenes in black and white, and then a glimpse of an exotic bird, all interspersed with monochrome grids and fuzzy static—a captcha at warp speed. The user’s task is simple: They tap on the right side of the screen whenever they see an animal in one of the pictures, and on the left side when they don’t.

Gut Microbiome Unlocks The Secrets Of Aging

A new study has shown how the gut microbiota of older mice can promote neural growth in young mice, leading to promising developments in future treatments. The research group, based in Nanyang Technological University (NTU) in Singapore, transferred the gut microbiota of older mice into the gut of younger mice with less developed gut fauna. This resulted in enhanced neurogenesis (neuron growth) in the brain and altered aging, suggesting that the symbiotic relationship between bacteria and their host can have significant benefits for health.

The past 20 years have seen a significant increase in the amount of research into the relationship between the host and the bacteria that live in or on it. The results of these studies have established an important role for this relationship in nutrition, metabolism, and behavior. The medical community hopes that these latest results could lead to the development of food-based treatment to help slow down the aging process.

In this study, the research team attempted to uncover the functional characteristics of the gut microbiota of an aging host. The researchers transplanted gut microbiota from old or young mice into young, germ-free mouse recipients.

Using mice, the team led by Professor Sven Pettersson from the NTU Lee Kong Chian School of Medicine, transplanted gut microbes from old mice (24 months old) into young, germ-free mice (6 weeks old). After eight weeks, the young mice had increased intestinal growth and production of neurons in the brain, known as neurogenesis.
The team showed that the increased neurogenesis was due to an enrichment of gut microbes that produce a specific short chain fatty acid, called butyrate.
 We’ve found that microbes collected from an old mouse have the capacity to support neural growth in a younger mouse,” said Prof Pettersson. “This is a surprising and very interesting observation, especially since we can mimic the neuro-stimulatory effect by using butyrate alone.”
 “These results will lead us to explore whether butyrate might support repair and rebuilding in situations like stroke, spinal damage and to attenuate accelerated ageing and cognitive decline”.
The study was published in Science Translational Medicine, and was undertaken by researchers from Singapore, UK, and Australia.



Biologists don’t understand the link between genes and behavior, so why should economists? Many outside critics of economics complain that it’s not a science. In response, most economists have steadily improved the quality of their empirical methods. But a few economists are taking a different tack by borrowing from natural science. Neuroeconomists, for example, have put experimental subjects in MRI machines to measure how their brains behave when they’re making economic decisions, in order to search for clues to the mechanisms behind everyday behavior. Recently, a few economists have sought to use genetics to augment their understanding of economic outcomes. This has become possible thanks to the advent of cheap genome sequencing and widely available databases of human genetic information. But there are a number of reasons this line of research is likely to do more harm than good, at least until biologists better understand the ways that genes affect human development.

One major foray into the field of geno-economics came from Quamrul Ashraf of Williams College and Oded Galor of Brown University. In a 2013 paper published in the American Economic Review — arguably the most prestigious journal in economics — Ashraf and Galor argue that genetic diversity exerts a big influence on economic developmentToo much diversity, they argue, and people don’t trust each other. Too little diversity, and original ideas are hard to come by. Thus, the optional amount of diversity is a happy medium — a population homogeneous enough to cooperate, but diverse enough to have originality. Looking at genetic data, they found that Europe and East Asia tend to have a medium range of genetic diversity, with Africa on the high end and the indigenous populations of the Americas and Oceania on the low end. Since Europe and East Asia contain the most industrialized nations, Ashraf and Galor concluded that the data supported their hypothesis. Another geno-economics paper was recently published in the Journal of Public Economics — also a top journal — by economists Daniel Barth, Nicholas Papageorge and Kevin Thom. Rather than tackling the broad sweep of international development as Ashraf and Galor did, Barth et al. tried to use genetics to explain differences in individual wealth, using the Health and Retirement Study, which measures wealth and various other financial information. For each individual, they obtained a polygenic score — a number that represents statistical differences in a large set of genes — that tends to be correlated with educational attainment. Restricting their analysis only to people of European descent, Barth et al. then showed that this genetic statistic is correlated with more success in investing, even after controlling for things like income and education. They concluded that genetic endowments help some people invest more successfully, leading them to build up wealth over time.